Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Transcatheter aortic valve implantation (TAVI) has spawned the evolution of novel catheter-
based therapies for a variety of cardiovascular conditions. Newer device iterations are …

731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

Transcatheter aortic valve replacement (TAVR) has become a safe and effective therapy for
patients with severe aortic stenosis (AS). In recent trials, the hemodynamic performance and …

Objectives The purpose of this study was to examine the impact of residual mitral
regurgitation (MR) on mortality in patients undergoing transcatheter aortic valve replacement …

Objectives: This study sought to analyze the clinical impact of the degree and improvement
of mitral regurgitation in TAVR recipients, validate the main imaging determinants of this …

Background: In patients with end-stage renal disease (ESRD), surgical aortic valve
replacement is associated with higher early and late mortality, and adverse outcomes …

As transcatheter aortic valve replacement becomes a more dominant treatment option
across all risk profiles, the frequency of encountering patients with multivalvular disease will …

Aims: We sought to determine the long-term outcome of high-risk patients who underwent
transcatheter aortic valve replacement (TAVR) with first-generation devices with a focus on …

Multivalvular disease (MVD) is common among patients with valvular disease, and has a
complex pathophysiology dependent on the specific combination of valve lesions. Diagnosis …